LIVE VIEW · EDITEditas Medicine, Inc.BiotechnologyEDIT research Sign up to open the full interactive terminal, save boards, and get alerts
EDIT · Live chart
Loading live chart
EDIT · Smart-money compositeas of Jul 30
+10LONGsmart-money positioning
-100 short0+100 long
Insiderno insider cluster in the l...
Congressno congressional trade in t...
13F fundsLONG
Short volumeFINRA short-volume is not c...
1 of 4 families contributing
EDIT · Recent signals
Point72 Asset Management, L.P. cut 84% of EDIT (2026Q1)HIGHSHORTJul 24
D. E. Shaw & Co., Inc. added +75% to EDIT (2026Q1)HIGHLONGJul 24
Q3-2025: Beat consensus by 7.3% - EPS $-0.28 vs $-0.3022 estimateMEDIUMLONGJun 12
Q4-2025: Beat consensus by 77.2% - EPS $-0.06 vs $-0.2633 estimateMEDIUMLONGJun 12
Q2-2025: Missed consensus by 63.8% - EPS $-0.63 vs $-0.3846 estimateMEDIUMSHORTJun 12
EDIT · Institutional holdersas of 2026Q1
RENAISSANCE TECHNOLOGIES LLC$9.8M+30.7%
RENAISSANCE TECHNOLOGIES LLC$6.2M+138.0%
TWO SIGMA INVESTMENTS, LP$5.5Mn/a
D. E. Shaw & Co., Inc.$4.8M+75.2%
RENAISSANCE TECHNOLOGIES LLC$4.4Mn/a
TWO SIGMA INVESTMENTS, LP$3.8M-5.1%
TWO SIGMA INVESTMENTS, LP$3.3M+3.1%
D. E. Shaw & Co., Inc.$2.3M+855.1%
Live alerts on EDIT
Live alerts on EDITGet pinged the moment insiders, congress, or 13F funds move on EDIT.Sign up to unlock
Options positioning and dealer gamma
Options positioning and dealer gammaDealer gamma, call and put walls, and expiry pressure for EDIT.Sign up to unlock
Build your own board
Build your own boardEvery ticker, your own layout, saved boards, and alerts in one terminal.Sign up to unlock